The interview highlights how First Ascent Biomedical is pioneering personalized treatments for pediatric cancer. By testing hundreds of FDA-approved drugs against each child’s tumor, the company identifies therapies most likely to work within days, emphasizing its mission to move beyond adult-adapted drugs to tailored solutions that give children a better chance at survival and recovery.